Cargando…
Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis
Radiomics is an emerging technology for imaging biomarker discovery and disease-specific personalized treatment management. This paper aims to determine the benefit of using multi-modality radiomics data from PET and MR images in the characterization breast cancer phenotype and prognosis. Eighty-fou...
Autores principales: | Huang, Shih-ying, Franc, Benjamin L., Harnish, Roy J., Liu, Gengbo, Mitra, Debasis, Copeland, Timothy P., Arasu, Vignesh A., Kornak, John, Jones, Ella F., Behr, Spencer C., Hylton, Nola M., Price, Elissa R., Esserman, Laura, Seo, Youngho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095872/ https://www.ncbi.nlm.nih.gov/pubmed/30131973 http://dx.doi.org/10.1038/s41523-018-0078-2 |
Ejemplares similares
-
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET
por: Hathi, Deep K., et al.
Publicado: (2020) -
Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL
por: Li, Wen, et al.
Publicado: (2016) -
Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial
por: Onishi, Natsuko, et al.
Publicado: (2020) -
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol
por: Jones, Ella F., et al.
Publicado: (2019) -
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer
por: Li, Wen, et al.
Publicado: (2020)